{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T07:37:22Z","timestamp":1776757042860,"version":"3.51.2"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2011,9,8]],"date-time":"2011-09-08T00:00:00Z","timestamp":1315440000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0024643","type":"journal-article","created":{"date-parts":[[2011,9,9]],"date-time":"2011-09-09T04:48:51Z","timestamp":1315543731000},"page":"e24643","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":39,"title":["A Selectable and Excisable Marker System for the Rapid Creation of Recombinant Poxviruses"],"prefix":"10.1371","volume":"6","author":[{"given":"Julia L.","family":"Rintoul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Don B.","family":"Gammon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"van Buuren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Garson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Jardine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Barry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,9,8]]},"reference":[{"key":"ref1","article-title":"Smallpox and Its Eradication","year":"1988"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2174\/157489106778777592","article-title":"Poxvirus cancer therapy.","volume":"1","author":"PA Gilbert","year":"2006","journal-title":"Recent Pat Antiinfect Drug Discov"},{"key":"ref3","first-page":"317","article-title":"Gene therapy with poxvirus vectors.","volume":"7","author":"D Moroziewicz","year":"2005","journal-title":"Curr Opin Mol Ther"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0378-1119(83)90163-4","article-title":"Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNA.","volume":"25","author":"GL Smith","year":"1983","journal-title":"Gene"},{"key":"ref5","first-page":"530","article-title":"[Genetic studies with mammalian poxviruses. I. Demonstration of recombination between two strains of vaccina virus.].","volume":"5","author":"F Fenner","year":"1958","journal-title":"Virology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1073\/pnas.79.5.1593","article-title":"Molecular genetics of vaccinia virus: demonstration of marker rescue.","volume":"79","author":"E Nakano","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/sj.cgt.7700066","article-title":"Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma.","volume":"6","author":"MJ Mastrangelo","year":"1999","journal-title":"Cancer Gene Ther"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/sj.cgt.7701098","article-title":"Modified vaccinia virus Ankara as a vector for suicide gene therapy.","volume":"15","author":"P Erbs","year":"2008","journal-title":"Cancer Gene Ther"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/0140-6736(92)92027-D","article-title":"Immunisation with canarypox virus expressing rabies glycoprotein.","volume":"339","author":"M Cadoz","year":"1992","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1200\/JCO.2009.25.0597","article-title":"Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer.","volume":"28","author":"PW Kantoff","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0264-410X(00)00191-2","article-title":"Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus\u2013poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans.","volume":"19","author":"N Kanesa-thasan","year":"2000","journal-title":"Vaccine"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e707","DOI":"10.1371\/journal.pone.0000707","article-title":"Extended follow-up following a phase 2b randomized trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya.","volume":"2","author":"P Bejon","year":"2007","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1158\/1078-0432.CCR-07-0704","article-title":"Vaccination of colorectal cancer patients with modified vaccinia ankara encoding the tumor antigen 5T4 (TroVax) given alongside chemotherapy induces potent immune responses.","volume":"13","author":"R Harrop","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ymthe.2005.06.481","article-title":"Recombinant vaccinia virus expressing interleukin-2 invokes anti-tumor cellular immunity in an orthotopic murine model of head and neck squamous cell carcinoma.","volume":"13","author":"S Dasgupta","year":"2006","journal-title":"Mol Ther"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1089\/10430349950018094","article-title":"Anti-tumor immunity elicited by a recombinant vaccinia virus expressing CD70 (CD27L).","volume":"10","author":"MG Lorenz","year":"1999","journal-title":"Hum Gene Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1158\/0008-5472.CAN-09-1510","article-title":"Myxoma virus virotherapy for glioma in immunocompetent animal models: optimizing administration routes and synergy with rapamycin.","volume":"70","author":"X Lun","year":"2010","journal-title":"Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/mt.2010.14","article-title":"Potent oncolytic activity of raccoonpox virus in the absence of natural pathogenicity.","volume":"18","author":"L Evgin","year":"2010","journal-title":"Mol Ther"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm0896-893","article-title":"Immunogenicity and protective efficacy of a tuberculosis DNA vaccine.","volume":"2","author":"K Huygen","year":"1996","journal-title":"Nat Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ymthe.2006.05.008","article-title":"Systemic armed oncolytic and immunologic therapy for cancer with JX-594, a targeted poxvirus expressing GM-CSF.","volume":"14","author":"JH Kim","year":"2006","journal-title":"Mol Ther"},{"key":"ref20","first-page":"8751","article-title":"Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes.","volume":"61","author":"JA McCart","year":"2001","journal-title":"Cancer Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1128\/JVI.49.3.857-864.1984","article-title":"General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.","volume":"49","author":"M Mackett","year":"1984","journal-title":"J Virol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0076-6879(87)53077-4","article-title":"Vaccinia virus as an expression vector.","volume":"153","author":"A Piccini","year":"1987","journal-title":"Methods Enzymol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e1000984","DOI":"10.1371\/journal.ppat.1000984","article-title":"Vaccinia virus-encoded ribonucleotide reductase subunits are differentially required for replication and pathogenesis.","volume":"6","author":"DB Gammon","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1128\/MCB.5.8.1918","article-title":"Neomycin resistance as a dominant selectable marker for selection and isolation of vaccinia virus recombinants.","volume":"5","author":"CA Franke","year":"1985","journal-title":"Mol Cell Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1128\/JVI.62.6.1849-1854.1988","article-title":"Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors.","volume":"62","author":"FG Falkner","year":"1988","journal-title":"J Virol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1128\/MCB.5.12.3403","article-title":"Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques.","volume":"5","author":"S Chakrabarti","year":"1985","journal-title":"Mol Cell Biol"},{"key":"ref27","first-page":"352","article-title":"E. coli beta-glucuronidase (GUS) as a marker for recombinant vaccinia viruses.","volume":"19","author":"MW Carroll","year":"1995","journal-title":"Biotechniques"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.virol.2005.06.049","article-title":"Bioluminescence imaging of vaccinia virus: effects of interferon on viral replication and spread.","volume":"341","author":"KE Luker","year":"2005","journal-title":"Virology"},{"key":"ref29","article-title":"Note for guidance on the quality, preclinical and clinical aspects of gene transfer medicinal products, <italic>The European Agency for the Evaluation of Medicinal Products<\/italic>, (London, 2001)."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"10856","DOI":"10.1128\/JVI.75.22.10856-10869.2001","article-title":"Insertions in the gG gene of pseudorabies virus reduce expression of the upstream Us3 protein and inhibit cell-to-cell spread of virus infection.","volume":"75","author":"GL Demmin","year":"2001","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1128\/JVI.64.6.3108-3111.1990","article-title":"Transient dominant selection of recombinant vaccinia viruses.","volume":"64","author":"FG Falkner","year":"1990","journal-title":"J Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s007050050303","article-title":"Transient marker stabilisation: a general procedure to construct marker-free recombinant vaccinia virus.","volume":"143","author":"F Scheiflinger","year":"1998","journal-title":"Arch Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e5175","DOI":"10.1371\/journal.pone.0005175","article-title":"A method for the generation of ectromelia virus (ECTV) recombinants: in vivo analysis of ECTV vCD30 deletion mutants.","volume":"4","author":"A Alejo","year":"2009","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1128\/JVI.02255-08","article-title":"The 3\u2032-to-5\u2032 exonuclease activity of vaccinia virus DNA polymerase is essential and plays a role in promoting virus genetic recombination.","volume":"83","author":"DB Gammon","year":"2009","journal-title":"J Virol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1073\/pnas.85.14.5166","article-title":"Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1.","volume":"85","author":"B Sauer","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0022-2836(81)90375-2","article-title":"Bacteriophage P1 site-specific recombination. I. Recombination between loxP sites.","volume":"150","author":"N Sternberg","year":"1981","journal-title":"J Mol Biol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"8599","DOI":"10.1128\/MCB.01062-06","article-title":"Role of the cyclic AMP response element in the bcl-2 promoter in the regulation of endogenous Bcl-2 expression and apoptosis in murine B cells.","volume":"26","author":"H Xiang","year":"2006","journal-title":"Mol Cell Biol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2172-10-28","article-title":"A kinase-dead knock-in mutation in mTOR leads to early embryonic lethality and is dispensable for the immune system in heterozygous mice.","volume":"10","author":"B Shor","year":"2009","journal-title":"BMC Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.tig.2005.04.009","article-title":"Transcriptional interference\u2013a crash course.","volume":"21","author":"KE Shearwin","year":"2005","journal-title":"Trends Genet"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/0042-6822(90)90367-Z","article-title":"Reverse guanine phosphoribosyltransferase selection of recombinant vaccinia viruses.","volume":"178","author":"SN Isaacs","year":"1990","journal-title":"Virology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1128\/JVI.02723-07","article-title":"Vaccinia virus DNA ligase recruits cellular topoisomerase II to sites of viral replication and assembly.","volume":"82","author":"YC Lin","year":"2008","journal-title":"J Virol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/0092-8674(93)90644-6","article-title":"Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting.","volume":"73","author":"H Gu","year":"1993","journal-title":"Cell"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.2144\/97236st07","article-title":"Compact, synthetic, vaccinia virus early\/late promoter for protein expression.","volume":"23","author":"S Chakrabarti","year":"1997","journal-title":"Biotechniques"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2144\/000112536","article-title":"In-fusion assembly: seamless engineering of multidomain fusion proteins, modular vectors, and mutations.","volume":"43","author":"B Zhu","year":"2007","journal-title":"Biotechniques"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/nar\/23.4.628","article-title":"A transient three-plasmid expression system for the production of high titer retroviral vectors.","volume":"23","author":"Y Soneoka","year":"1995","journal-title":"Nucleic Acids Res"},{"key":"ref46","first-page":"119","article-title":"Orthopoxvirus diagnostics.","volume":"269","author":"H Meyer","year":"2004","journal-title":"Methods Mol Biol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/bioinformatics\/btm039","article-title":"Gepard: a rapid and sensitive tool for creating dotplots on genome scale.","volume":"23","author":"J Krumsiek","year":"2007","journal-title":"Bioinformatics"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0024643","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T12:28:20Z","timestamp":1592915300000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0024643"}},"subtitle":[],"editor":[{"given":"William P.","family":"Halford","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,9,8]]},"references-count":47,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2011,9,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0024643","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,8]]}}}